Semaglutides and the next public health revolution
It is hard to overstate the transformational public health benefits of anti-hypertensives and statins for blood pressure and serum cholesterol control. For a modest cost, these drugs not only mitigate human suffering but save billions, if not trillions, of dollars by avoiding costly surgical interventions. The repurposing of anti-diabetic drugs like semaglutide and tirzepatide for […]